Skip to main content

Oncternal Therapeutics, Inc.

ONCTDelisted Mar 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001260990

Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.

13F holders, Q1 2024

Institutional positions in Oncternal Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
24
−16 vs. Q4 2023
Shares held
450.0K
+27.7K (+6.6%) vs. Q4 2023Converted for a 1-for-20 split
Total value
$4.05M
−$478.2K (−10.6%) vs. Q4 2023
New holders
7
3 more added
Sold out
23
2 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ONCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 24 institutions
Q1 2021: 67 institutionsQ2 2021: 85 institutionsQ3 2021: 77 institutionsQ4 2021: 84 institutionsQ1 2022: 79 institutionsQ2 2022: 75 institutionsQ3 2022: 61 institutionsQ4 2022: 59 institutionsQ1 2023: 55 institutionsQ2 2023: 53 institutionsQ3 2023: 52 institutionsQ4 2023: 41 institutionsQ1 2024: 24 institutionsQ2 2024: 26 institutionsQ3 2024: 23 institutionsQ4 2024: 4 institutionsQ1 2025: 0 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2024: $4.05M
Q1 2021: $82.5MQ2 2021: $65.2MQ3 2021: $56.8MQ4 2021: $30.5MQ1 2022: $18.6MQ2 2022: $12.6MQ3 2022: $8.79MQ4 2022: $9.31MQ1 2023: $7.86MQ2 2023: $3.26MQ3 2023: $2.81MQ4 2023: $4.53MQ1 2024: $4.05MQ2 2024: $3.67MQ3 2024: $471.0KQ4 2024: $10Q1 2025: $0Q2 2025: $74Q3 2025: $73Q4 2025: $169Q1 2026: $74Q2 2026: $75
Institutions holding ONCT and their total value by quarter
QuarterHoldersValue
Q2 20261$75
Q1 20261$74
Q4 20252$169
Q3 20251$73
Q2 20251$74
Q1 20250$0
Q4 20244$10
Q3 202423$471.0K
Q2 202426$3.67M
Q1 202424$4.05M
Q4 202341$4.53M
Q3 202352$2.81M
Q2 202353$3.26M
Q1 202355$7.86M
Q4 202259$9.31M
Q3 202261$8.79M
Q2 202275$12.6M
Q1 202279$18.6M
Q4 202184$30.5M
Q3 202177$56.8M
Q2 202185$65.2M
Q1 202167$82.5M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Oncternal Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding ONCT in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc143,043$1.29M0.00%00.0%UnchangedConverted for a 1-for-20 split
Millennium Management LLC103,095$927.9K0.00%00.0%UnchangedConverted for a 1-for-20 split
BlackRock Inc.39,278$353.5K0.00%00.0%UnchangedConverted for a 1-for-20 split
Quantum Private Wealth, LLC27,806$250.3K0.09%+27,806New
Dimensional Fund Advisors LP25,892$233.0K0.00%+25,892New
Richmond Brothers, Inc.24,696$222.3K0.41%00.0%UnchangedConverted for a 1-for-20 split
Geode Capital Management, LLC24,079$216.7K0.00%+24,079New
Brighton Jones LLC16,923$152.3K0.01%+16,923New
Renaissance Technologies LLC16,905$152.0K0.00%+545+3.3%AddedConverted for a 1-for-20 split
Morgan Stanley10,800$97.2K0.00%+6,151+132.3%AddedConverted for a 1-for-20 split
Susquehanna International Group, LLP10,194$91.7K0.00%+10,194New
ADAR1 Capital Management, LLC2,472$22.2K0.01%+2,472New
Acadian Asset Management LLC1,949$17.0K0.00%−1,690−46.4%ReducedConverted for a 1-for-20 split
JPMorgan Chase & Co1,004$9.04K0.00%00.0%UnchangedConverted for a 1-for-20 split
Tower Research Capital LLC (TRC)664$5.98K0.00%+416+167.6%AddedConverted for a 1-for-20 split
Wells Fargo & Company322$2.90K0.00%00.0%UnchangedConverted for a 1-for-20 split
Advisor Group Holdings, Inc.287$2.58K0.00%−156−35.1%ReducedConverted for a 1-for-20 split
North Star Investment Management Corp.250$2.25K0.00%00.0%UnchangedConverted for a 1-for-20 split
BNP Paribas Arbitrage, SA182$1.64K0.00%00.0%UnchangedConverted for a 1-for-20 split
UBS Group AG100$9000.00%00.0%UnchangedConverted for a 1-for-20 split
Truvestments Capital LLC22$1980.00%00.0%UnchangedConverted for a 1-for-20 split
Steward Partners Investment Advisory, LLC15$1350.00%00.0%UnchangedConverted for a 1-for-20 split
Lindbrook Capital, LLC15$1350.00%00.0%UnchangedConverted for a 1-for-20 split
Nemes Rush Group LLC3$270.00%+3New
Pasadena Private Wealth, LLC0$00.00%−25,000−100.0%Sold outConverted for a 1-for-20 split
LPL Financial LLC0$00.00%−8,573−100.0%Sold outConverted for a 1-for-20 split
State Street Corp0$00.00%−8,070−100.0%Sold outConverted for a 1-for-20 split
Ieq Capital, LLC0$00.00%−7,222−100.0%Sold outConverted for a 1-for-20 split
Northern Trust Corp0$00.00%−4,235−100.0%Sold outConverted for a 1-for-20 split
Two Sigma Advisers, LP0$00.00%−4,180−100.0%Sold outConverted for a 1-for-20 split
Two Sigma Investments, LP0$00.00%−3,734−100.0%Sold outConverted for a 1-for-20 split
Axxcess Wealth Management, LLC0$00.00%−3,518−100.0%Sold outConverted for a 1-for-20 split
Two Sigma Securities, LLC0$00.00%−2,938−100.0%Sold outConverted for a 1-for-20 split
Citadel Advisors LLC0$00.00%−2,714−100.0%Sold outConverted for a 1-for-20 split
Regents of the University of California0$00.00%−2,678−100.0%Sold outConverted for a 1-for-20 split
Balboa Wealth Partners0$00.00%−2,375−100.0%Sold outConverted for a 1-for-20 split
Creative Planning0$00.00%−1,966−100.0%Sold outConverted for a 1-for-20 split
Charles Schwab Investment Management Inc0$00.00%−1,612−100.0%Sold outConverted for a 1-for-20 split
Beta Wealth Group, Inc.0$00.00%−1,600−100.0%Sold outConverted for a 1-for-20 split
Aureus Asset Management, LLC0$00.00%−1,511−100.0%Sold outConverted for a 1-for-20 split
Valeo Financial Advisors, LLC0$00.00%−1,177−100.0%Sold outConverted for a 1-for-20 split
IPG Investment Advisors LLC0$00.00%−1,166−100.0%Sold outConverted for a 1-for-20 split
XTX Topco Ltd0$00.00%−975−100.0%Sold outConverted for a 1-for-20 split
Bank of America Corp0$00.00%−2−100.0%Sold outConverted for a 1-for-20 split
Delta Asset Management LLC0$00.00%−0−100.0%Sold outConverted for a 1-for-20 split
Cetera Trust Company, N.A0$00.00%−0−100.0%Sold outConverted for a 1-for-20 split
Qube Research & Technologies Ltd0$00.00%−0−100.0%Sold outConverted for a 1-for-20 split
Coppell Advisory Solutions LLC––––Not filed